Resource and Technical AdvanceIn-Press PreviewBone biologyNeuroscience Open Access | 10.1172/jci.insight.176962
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Ledbetter, D. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by de Almeida, R. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Wu, X. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Naveh, A. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Patel, C. in: JCI | PubMed | Google Scholar |
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Gonzalez, Q. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Beckham, T. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by North, R. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Rhines, L. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Li, J. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Ghia, A. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Aten, D. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Tatsui, C. in: JCI | PubMed | Google Scholar
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, United States of America
2Novocure Ltd., Haifa, Israel
3Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America
4Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, United States of America
5Department of Radiation Oncology, CNS/Pediatrics Section, The Univeristy of Texas MD Anderson Cancer Center, Houston, United States of America
6Department of Radiation Oncology, CNS/Pediatrics Section, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
7Department of Diagnostic Imaging, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
8Department of Neurosurgery, The Univerisity of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Alvarez-Breckenridge, C. in: JCI | PubMed | Google Scholar
Published March 21, 2024 - More info
Spine metastases can result in severe neurologic compromise and decreased overall survival. Despite treatment advances, local disease progression is frequent, highlighting the need for novel therapies. Tumor treating fields (TTFields) impair tumor cell replication and are influenced by properties of surrounding tissue. We hypothesize bone’s dielectric properties will enhance TTFields mediated suppression of tumor growth in spine metastasis models. Computational modeling of TTFields intensity was performed following surgical resection of a spinal metastasis and demonstrated enhanced TTFields intensity within the resected vertebral body. Additionally, luciferase-tagged human KRIB osteosarcoma and A549 lung adenocarcinoma cell lines were cultured in demineralized bone grafts and exposed to TTFields. Following TTFields exposure, BLI signal decreased 10-80% of baseline while control cultures displayed 4.48-9.36 fold increase in signal. Lastly, TTFields were applied in an orthotopic murine model of spinal metastasis. After 21 days of treatment, control mice demonstrated a 5-fold increase in BLI signal compared to TTFields treated mice. TTFields similarly prevented tumor invasion into the spinal canal and development of neurologic symptoms. Our data suggest that TTFields can be leveraged as a local therapy within minimally-conductive bone of spine metastases. This provides the groundwork for future studies investigating TTFields for patients with treatment-refractory spine metastases.